FDA-approved neurotoxin formulation by Daewoong Pharmaceuticals (KOSDAQ:069620) containing 200U Clostridium Botulinum CBFC26. Clinically proven to reduce moderate-to-severe glabellar lines with 94% patient satisfaction in phase III trials. Provides wrinkle reduction within 72hrs and lasting efficacy up to 6.2 months (JAMA Dermatology 2022).

Patented Stabilization Technology:
Utilizes Daewoong’s proprietary NabotaCore™ manufacturing process with:
• 0.22μm sterile filtration
• Lyophilized vacuum sealing
• C. botulinum strain CBFC26
• 3-stage potency validation

Pharmaceutical Specifications:
📦 1 Type A vial/box (200U/vial)
🧪 900kDa complex molecular weight
🌡️ Store at 2-8°C protected from light
⚖️ Net weight: 30g ±0.15g

Reconstitution Protocol:
1. Add 5ml sterile saline (0.9% NaCl)
2. Gentle rotational mixing (≤3 cycles)
3. Use 30G×½” needle for injection
4. Max 50U per treatment session
5. Follow FDA muscle mapping guidelines

*Prescription-only medical device. Administration requires valid medical license. Individual results may vary ±18% based on muscle mass and metabolism. Report adverse events to MedWatch (FDA) within 72hrs. Contraindicated in pregnancy and neuromuscular disorders.